Terms ending in 2036
Every in-force patent on Nantomics, LLC's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,487,078 | Compositions and Methods of Targeting Mutant K-Ras In force · High confidence | Nantbio, Inc. | In force | High confidence | |
| US 10,620,184 | SRM/MRM Assay for the Cyclin-Dependent Kinase Inhibitor 2A (p16) protein In force · Medium confidence | Nantomics, LLC | In force | Medium confidence | |
| US 11,011,273 | Pathway Analysis for Identification of Diagnostic Tests In force · Medium confidence | Nantbio, Inc. | In force | Medium confidence | |
| US 10,525,040 | Compositions and Methods of RIT1 Inhibition In force · High confidence | Nantomics, LLC | In force | High confidence | |
| US 10,736,884 | Compositions and Methods of RIT1 Inhibition In force · High confidence | Nant Holdings IP, LLC | In force | High confidence | |
| US 12,404,490 | AGGF1 Immunogenic Compositions In force · High confidence | Nantomics, LLC | In force | High confidence | |
| US 12,793,811 | Systems And Methods For High-Accuracy Variant Calling In force · Medium confidence | Nantomics, LLC | In force | Medium confidence | |
| US 10,339,274 | Viral Neoepitopes and Uses Thereof In force · High confidence | Nantomics, LLC | In force | High confidence | |
| US 11,623,001 | Compositions And Methods For Viral Cancer Neoepitopes In force · High confidence | Nantomics, LLC | In force | High confidence | |
| US 12,080,382 | Viral Neoepitopes and Uses Thereof In force · High confidence | Nantomics, LLC | In force | High confidence |
10 of 10 patents shown. Soonest term end first, then patent number.
8 of these are in force and held by Nantomics, LLC.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.